美国印第安或阿拉斯加原住民糖尿病患者的主要不良肾脏事件风险
该研究基于Providence健康系统电子健康记录,纳入2013-2022年成人糖尿病患者,比较美国印第安或阿拉斯加原住民(AI/AN)与非西班牙裔白人主要不良肾脏事件(MAKE)风险。倾向评分匹配后,AI/AN人群MAKE风险显著更高(HR 1.20,95%CI 1.15-1.27),社会因素和医疗利用是重要预测因素。
要点
- AI/AN糖尿病患者MAKE风险比非西班牙裔白人高20%(HR 1.20)。
- 社会脆弱性指数升高和住院与MAKE风险增加相关。
- 更多初级保健就诊与MAKE风险降低相关(HR 0.78)。
核心结论
- AI/AN糖尿病患者MAKE风险显著增加,社会因素和医疗利用对风险预测有重要贡献。
研究设计与样本
- 基于Providence健康系统2013-2022年电子健康记录,识别AI/AN成人糖尿病患者(N=6103)和非西班牙裔白人参照人群(N=354283),采用倾向评分1:3匹配,Kaplan-Meier和Cox模型分析。
主要发现
- AI/AN人群较参照人群更年轻(平均54±15岁 vs 62±14岁),血红蛋白A1c更高(平均7.4±2.2% vs 6.9%±1.8%)。
- 中位随访4.1年(IQR 2.0-6.4)期间,AI/AN人群MAKE发生率为26%(n=1614),参照人群为24%(n=85920)。
- 倾向评分匹配后,AI/AN人群MAKE生存估计显著更低(P<0.0001)。
- 调整后Cox模型显示,AI/AN人群MAKE风险增加(HR 1.20,95%CI 1.15-1.27),社会脆弱性指数升高(HR 1.05,95%CI 1.05-1.05)和住院(HR 1.98,95%CI 1.95-2.01)与风险增加相关,更多初级保健就诊与风险降低相关(HR 0.78,95%CI 0.77-0.79)。
临床怎么用
- 对AI/AN糖尿病患者应关注社会健康驱动因素和医疗利用模式,以识别MAKE高风险个体。
- 增加初级保健就诊可能有助于降低MAKE风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
KEY POINTS: Knowledge of the risk of major adverse kidney events in the American Indian or Alaska Native population with diabetes is limited. Compared with the non-Hispanic White population, the American Indian or Alaska Native population was younger with poorer glycemic control. This population had a 20% higher risk of major adverse kidney events with social drivers of health and health care utilization as key predictors. BACKGROUND: CKD and diabetes disproportionately affect the American Indian (AI) or Alaska Native (AN) population, but understanding of major adverse kidney events (MAKE) in this population is limited. METHODS: Electronic health records from the Providence health system identified the AI or AN adult population with diabetes during 2013-2022. A 1-year window surrounding diabetes cohort entry was used to collect baseline data. Kaplan-Meier analyses assessed MAKE (≥40% eGFR decline, eGFR <15 ml/min per 1.73 m 2 , dialysis or kidney transplant, and all-cause death) with propensity score matching (1:3) of AI or AN people to reference individuals (non-Hispanic White) by demographics and clinical characteristics. Cox proportional hazards modeling estimated associations between demographic, clinical, social, and health care utilization variables and MAKE. RESULTS: The AI or AN population ( N =6103) was younger (mean±SD age 54±15 years) with higher hemoglobin A1c (mean 7.4±2.2 mg/dl) compared with the reference population ( N =354,283; age 62±14 years; hemoglobin A1c 6.9%±1.8%). During a median follow-up of 4.1 (interquartile range, 2.0-6.4) years, the AI or AN population experienced a higher frequency of MAKE (26%, n =1614) than the reference population (24%, n =85,920). With propensity score matching, MAKE survival estimates were significantly lower in the AI or AN population ( P < 0.0001). In the adjusted Cox model, increased MAKE risk was observed for the AI or AN population (versus reference population, hazard ratio [HR] 1.20, 95% confidence interval [CI], 1.15 to 1.27), higher social vulnerability index (HR, 1.05; 95% CI, 1.05 to 1.05), and hospitalization (HR, 1.98; 95% CI, 1.95 to 2.01), while more primary care visits were associated with lower MAKE risk (HR, 0.78; 95% CI, 0.77 to 0.79). CONCLUSION: The risk of MAKE was significantly increased in the AI or AN population with diabetes. Social factors and health care utilization importantly contributed to risk prediction for MAKE.
引用
- Zemke A, Mayhand KN, Alicic RZ, et al. Major Adverse Kidney Events in the American Indian or Alaska Native Population with Diabetes. Clin J Am Soc Nephrol. 2026. PMID: 42335044. doi:10.2215/CJN.0000001121
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。